Similar articles

• Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.

  Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F. Bilsky EJ, et al. J Pharmacol Exp Ther. 1996 Apr;277(1):484-90. J Pharmacol Exp Ther. 1996. PMID: 8613958
• Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.

  Wang HY, Friedman E, Olmstead MC, Burns LH. Wang HY, et al. Neuroscience. 2005;135(1):247-61. doi: 10.1016/j.neuroscience.2005.06.003. Neuroscience. 2005. PMID: 16084657
• In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.

  Wells JL, Bartlett JL, Ananthan S, Bilsky EJ. Wells JL, et al. J Pharmacol Exp Ther. 2001 May;297(2):597-605. J Pharmacol Exp Ther. 2001. PMID: 11303048
• Interactions of narcotic antagonists with receptor sites.

  Goldstein A. Goldstein A. Adv Biochem Psychopharmacol. 1973;8(0):471-81. Adv Biochem Psychopharmacol. 1973. PMID: 4212101 Review. No abstract available.
• Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability.

  Crain SM, Shen KF. Crain SM, et al. Pain. 2000 Feb;84(2-3):121-31. doi: 10.1016/s0304-3959(99)00223-7. Pain. 2000. PMID: 10666516 Review.